Literature DB >> 17826767

Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.

María C Sánchez1, Jose D Luna, Pablo F Barcelona, Ana L Gramajo, Patricio C Juarez, Clelia M Riera, Gustavo A Chiabrando.   

Abstract

Panretinal photocoagulation (PRP) reduces the incidence of severe visual loss in proliferative diabetic retinopathy (PDR). The aim of the study was to determine the effect of PRP on the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, and also on the alpha(2)-Macroglobulin (alpha(2)M) proteolytic state in the vitreous of eyes with PDR. Vitreous samples were obtained from patients undergoing vitrectomy for the treatment of retinal diseases: 17 with PDR and eight with idiopathic macular hole (MH). Qualitative evaluation of the MMP-2 and MMP-9 activation status was performed by gelatin zymography and quantitative assay was carried out for vitreous total protein content and alpha(2)M. The proteolytic state of alpha(2)M was evaluated by Western blotting. Although all vitreous samples contained proMMP-2, increased proMMP-9 and active MMP-9 were detected in PDR samples without PRP. In addition, after PRP the proMMP-9 activity was significantly decreased, whereas the proMMP-2 activity was not affected. Enhanced total protein and alpha(2)M concentrations were observed in all vitreous samples from PDR patients with and without previous PRP compared with samples from patients with MH. However, a differential proteolytic state of alpha(2)M, expressed as 180/85-90kDa ratio, was detected among PDR patients with and without PRP treatment. Whereas a low 180/85-90kDa ratio of alpha(2)M in vitreous of PDR patients without PRP was observed, a high proportion of 180kDa subunit was principally detected in PDR with PRP. These results demonstrate that PDR occurs with an enhanced activity of MMP-9 and activation of alpha(2)M by proteinases, which is reversed after PRP. In addition, we suggest that alpha(2)M plays a key role in the control and regulation of the ocular neovascularization involved in the pathogenesis of ischemic retinal diseases such as PDR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826767     DOI: 10.1016/j.exer.2007.07.018

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

1.  Restoration of retinal structure and function after selective photocoagulation.

Authors:  Alexander Sher; Bryan W Jones; Philip Huie; Yannis M Paulus; Daniel Lavinsky; Loh-Shan S Leung; Hiroyuki Nomoto; Corinne Beier; Robert E Marc; Daniel Palanker
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

2.  IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model.

Authors:  Valeria E Lorenc; Paula V Subirada Caldarone; María C Paz; Darío G Ferrer; José D Luna; Gustavo A Chiabrando; María C Sánchez
Journal:  Mol Neurobiol       Date:  2017-01-17       Impact factor: 5.590

3.  Immunohistochemical localization of low density lipoprotein receptor-related protein 1 and alpha(2)-Macroglobulin in retinal and choroidal tissue of proliferative retinopathies.

Authors:  P F Barcelona; J D Luna; G A Chiabrando; C P Juarez; I A Bhutto; T Baba; D S McLeod; M C Sánchez; G A Lutty
Journal:  Exp Eye Res       Date:  2010-06-01       Impact factor: 3.467

4.  A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.

Authors:  Pablo F Barcelona; H Uri Saragovi
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

5.  HuoXueJieDu Formula Alleviates Diabetic Retinopathy in Rats by Inhibiting SOCS3-STAT3 and TIMP1-A2M Pathways.

Authors:  Hongliang Wang; Wei Xing; Shijie Tang; Zhenglin Wang; Tiantian Lv; Yan Wu; Shuzhen Guo; Chun Li; Jing Han; Ruixin Zhu; Wei Wang
Journal:  Int J Genomics       Date:  2017-11-29       Impact factor: 2.326

6.  Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF.

Authors:  Magali E Ridano; Paula V Subirada; María C Paz; Valeria E Lorenc; Juan C Stupirski; Ana L Gramajo; José D Luna; Diego O Croci; Gabriel A Rabinovich; María C Sánchez
Journal:  Oncotarget       Date:  2017-05-16

7.  The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.

Authors:  Tamara Jefferson; Ulrich Auf dem Keller; Caroline Bellac; Verena V Metz; Claudia Broder; Jana Hedrich; Anke Ohler; Wladislaw Maier; Viktor Magdolen; Erwin Sterchi; Judith S Bond; Arumugam Jayakumar; Heiko Traupe; Athena Chalaris; Stefan Rose-John; Claus U Pietrzik; Rolf Postina; Christopher M Overall; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2012-09-01       Impact factor: 9.261

8.  Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms.

Authors:  Amy R Wyatt; Patrick Constantinescu; Heath Ecroyd; Christopher M Dobson; Mark R Wilson; Janet R Kumita; Justin J Yerbury
Journal:  FEBS Lett       Date:  2013-01-23       Impact factor: 4.124

9.  Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.

Authors:  Jin-Woo Kwon; Jin A Choi; Donghyun Jee
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Association of salivary alpha 2-macroglobulin levels and clinical characteristics in type 2 diabetes.

Authors:  Tsung-Ju Chung; Kai-Yuen Hsu; Jui-Hung Chen; Jhih-Syuan Liu; Hsiao-Wen Chang; Peng-Fei Li; Chia-Luen Huang; Yi-Shing Shieh; Chien-Hsing Lee
Journal:  J Diabetes Investig       Date:  2015-07-14       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.